The Cardiac Effects Of Hydroxychloroquine In Immune-mediated Rheumatologic Diseases
Journal of the American Academy of Physician Assistants
Hydroxychloroquine, when used to treat patients with rheumatoid arthritis or systemic lupus erythematosus, has been found to reduce cardiovascular disease (CVD). The drug also has been associated with cardiac adverse reactions such as conduction abnormalities. This article reviews the reduction of CVD and the cardiac adverse reactions associated with hydroxychloroquine.
Weidman-Evans, Emily and Porter, Mandy, "The Cardiac Effects Of Hydroxychloroquine In Immune-mediated Rheumatologic Diseases" (2022). School of Allied Health Professions Faculty Publications. 19.